Rivus’ fat-trimming therapy nabs $35M to harness our own biology against a host of diseases

Rivus’ fat-trimming therapy nabs $35M to harness our own biology against a host of diseases

Submitted by admin on July 20, 2021 - 12:27pm
Source: 
Fierce Biotech
News Tags: 
Rivus Pharmaceuticals
type 2 diabetes
NASH
hypertriglyceridemia
heart failure with preserved ejection fraction
Headline: 
Rivus’ fat-trimming therapy nabs $35M to harness our own biology against a host of diseases
snippet: 

Rivus Pharmaceuticals is going after an alphabet soup of diseases: Type 2 diabetes; severe hypertriglyceridemia (SHTG); non-alcoholic steatohepatitis (NASH); and heart failure with preserved ejection fraction (HFpEF).

Do Not Allow Advertisers to Use My Personal information